About Us
Mission:
To enhance the benefits of applying AI to healthcare and drug discovery for the welfare of society.
Vision:
To be the No.1 player aiding in global drug discovery using AI in 2031.
Values:
Agape
Agility
Acumen
Agape: Stands for divine love and creative wisdom to benefit humanity.
Agility: Speed in execution and bringing good things to life.
Acumen: Intellectual thirst and skilled execution.
Who We Are
We are a team of engineers, Business professionals and entrepreneurs based in South India aiming at creating traction in the real life applications of protein folding visualization, led by Deepmind’s AI in Alphafold2. We are keen on popularizing the technology and encouraging adaptation of its know-how in solving real life needs in industry, particularly the Pharmaceutical Drug Discovery process. Since we have work experience in Information Technology, Pharma and Consulting, we seek to put forward a model of easy adaptation of this technology globally, particularly in Asia Pacific. We are excited about the prospects of this pioneering work!
Human intelligence: shapes the modern world
It has always been fascinated by human intelligence – it shaped the modern world we live in today. Intelligence allows us to learn, imagine, cooperate, create, communicate, and so much more. By better understanding different aspects of intelligence, we can use this knowledge as inspiration to build novel computer systems that learn to find solutions to difficult problems on their own. Like the Hubble telescope that helped us look deeper into space, these tools are already expanding human knowledge and making positive global impact. Guided by safety and ethics, this invention could help society find answers to some of the world’s most pressing and fundamental scientific challenges.
An initiative to find the solutions by using AI
When started DeepMind in 2010, there was far less interest in the field of AI than there is today. To accelerate the field, it took an interdisciplinary approach, bringing together new ideas and advances in machine learning, neuroscience, engineering, mathematics, simulation and computing infrastructure, along with new ways of organising scientific endeavour. Deep mind joined forces with Google in 2014 to accelerate our work, while continuing to set research agenda. Their programs have learned to diagnose eye diseases as effectively as the world’s top doctors, to save 30% of the energy used to keep data centres cool, and to predict the complex 3D shapes of proteins – which could one day transform how drugs are invented.